Real-time enrollment status for this recurrent supratentorial glioblastoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 1:50 PM UTC
| NCT Number | NCT06177964 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Supratentorial Glioblastoma |
| Phase | PHASE2 |
| Target Enrollment | 92 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Darell Bigner |
| Last Updated on CT.gov | August 17, 2025 (Aug 17, 2025) |
As of July 19, 2026: Clinical trial NCT06177964 is currently recruiting participants. This phase2 study for recurrent supratentorial glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Darell Bigner. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06177964 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06177964 was last updated Aug 17, 2025 (August 17, 2025). HelloStudys verifies this status automatically.